D
CRISPR Therapeutics AG CRSP
$54.13 -$0.19-0.35% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 72.53% 71.63% -82.26% -- -99.26%
Total Other Revenue -- -- -- -- --
Total Revenue 72.53% 71.63% -82.26% -- -99.26%
Cost of Revenue -13.04% 5.57% -28.65% -18.23% -9.50%
Gross Profit 13.37% -5.30% -153.99% 18.76% -72.96%
SG&A Expenses -2.90% 7.48% 9.98% -4.77% 2.36%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -11.74% 5.81% -23.81% -16.37% -8.14%
Operating Income 12.02% -5.57% -192.82% 16.83% -58.85%
Income Before Tax -65.65% -16.42% -140.87% 23.87% -62.88%
Income Tax Expenses 0.39% 53.18% 200.43% 112.62% 39.44%
Earnings from Continuing Operations -64.98% -16.64% -141.76% 23.37% -62.60%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -64.98% -16.64% -141.76% 23.37% -62.60%
EBIT 12.02% -5.57% -192.82% 16.83% -58.85%
EBITDA 12.29% -5.84% -180.21% 17.33% -62.21%
EPS Basic -60.91% -11.02% -138.94% 28.60% -51.44%
Normalized Basic EPS 13.48% -10.81% -138.10% 29.07% -51.71%
EPS Diluted -61.07% -10.66% -139.88% 28.48% -51.59%
Normalized Diluted EPS 13.48% -10.81% -138.89% 29.07% -51.71%
Average Basic Shares Outstanding 2.53% 5.07% 7.25% 7.33% 7.37%
Average Diluted Shares Outstanding 2.53% 5.07% 5.09% 7.33% 7.37%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --